Cargando…

An adolescent rat model of vincristine-induced peripheral neuropathy

Childhood acute lymphoblastic leukemia (ALL) is a significant clinical problem that can be effectively treated with vincristine, a vinca alkaloid-based chemotherapeutic agent. However, nearly all children receiving vincristine treatment develop vincristine-induced peripheral neuropathy (VIPN). The i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ai-Ling, Crystal, Jonathon D., Lai, Yvonne Y., Sajdyk, Tammy J., Renbarger, Jamie L., Hohmann, Andrea G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605395/ https://www.ncbi.nlm.nih.gov/pubmed/34841128 http://dx.doi.org/10.1016/j.ynpai.2021.100077

Ejemplares similares

A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral Neuropathy
por: Verma, Parul, et al.
Publicado: (2020)

Antinociceptive Effect of Memantine and Morphine on Vincristine-induced Peripheral Neuropathy in Rats
por: Park, Byoung Yoon, et al.
Publicado: (2010)

Hydroethanolic extract of Lavandula angustifolia ameliorates vincristine-induced peripheral neuropathy in rats
por: Sahranavard, Shamim, et al.
Publicado: (2022)

Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients
por: van de Velde, Mirjam E., et al.
Publicado: (2022)

Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes
por: Wright, Galen E.B., et al.
Publicado: (2018)

Vincristine-Induced Cranial Neuropathy
por: TALEBIAN, Ahmad, et al.
Publicado: (2014)

Hydroethanolic Stem Bark Extract of Burkea africana Attenuates Vincristine-Induced Peripheral Neuropathy in Rats
por: Jibira, Yakubu, et al.
Publicado: (2020)

Antiallodynic and anti-inflammatory effects of intrathecal R-PIA in a rat model of vincristine-induced peripheral neuropathy
por: Kim, Kyungmi, et al.
Publicado: (2020)

The Involvement of Central Noradrenergic Pathway in the Analgesic Effect of Bee Venom Acupuncture on Vincristine-Induced Peripheral Neuropathy in Rats
por: Li, Daxian, et al.
Publicado: (2020)

Minocycline Prevents the Development of Mechanical Allodynia in Mouse Models of Vincristine-Induced Peripheral Neuropathy
por: Starobova, H., et al.
Publicado: (2019)

Vincristine-Induced Peripheral Neuropathy in Children With Malignancy and the Effect of Missed Doses on Treatment Success
por: Eker, Nurşah, et al.
Publicado: (2023)

Electrophysiologic Patterns of Symptomatic Vincristine-Induced Peripheral Neuropathy in Children with Acute Lymphocytic Leukemia
por: Jeong, Jae-Gyeong, et al.
Publicado: (2023)

Measuring vincristine-induced peripheral neuropathy in children with cancer: validation of the Dutch pediatric–modified Total Neuropathy Score
por: Schouten, S. M., et al.
Publicado: (2019)

Vitamin D3 Promotes Structural and Functional Recovery After Vincristine-Induced Peripheral Neuropathy in Rats: An Experimental Study
por: Erdem, Hüseyin, et al.
Publicado: (2023)

Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy
por: Hatzl, Stefan, et al.
Publicado: (2021)

The association between vincristine‐induced peripheral neuropathy and health‐related quality of life in children with cancer
por: van de Velde, Mirjam E., et al.
Publicado: (2021)

Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy in Children with Cancer: A Systematic Review and Meta-Analysis
por: Uittenboogaard, Aniek, et al.
Publicado: (2022)

The Antiallodynic Effect of Nefopam on Vincristine-Induced Neuropathy in Mice
por: Lee, Jin Young, et al.
Publicado: (2020)

Immune-mediated vincristine-induced neuropathy: Unlocking therapies
por: Savelieff, Masha G., et al.
Publicado: (2021)

Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release
por: Starobova, Hana, et al.
Publicado: (2021)

Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment
por: Triarico, Silvia, et al.
Publicado: (2021)

The Ameliorative Effect of Thymoquinone on Vincristine-Induced Peripheral Neuropathy in Mice by Modulating Cellular Oxidative Stress and Cytokine
por: Alenezi, Sattam Khulaif
Publicado: (2022)

Population Pharmacokinetics of Vincristine Related to Infusion Duration and Peripheral Neuropathy in Pediatric Oncology Patients
por: van de Velde, Mirjam Esther, et al.
Publicado: (2020)

Through Its Powerful Antioxidative Properties, L-Theanine Ameliorates Vincristine-Induced Neuropathy in Rats
por: Yang, Chih-Chuan, et al.
Publicado: (2023)

Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor
por: Yang, Qing-Yan, et al.
Publicado: (2021)

Contribution of common and rare genetic variants in CEP72 on vincristine‐induced peripheral neuropathy in brain tumour patients
por: Klumpers, Marije J., et al.
Publicado: (2022)

Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review
por: Madsen, Marie Lindhard, et al.
Publicado: (2019)

Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy
por: Li, Yang, et al.
Publicado: (2023)

Mechanistic physiology-based pharmacokinetic modeling to elucidate vincristine-induced peripheral neuropathy following treatment with novel kinase inhibitors
por: Pilla Reddy , Venkatesh, et al.
Publicado: (2021)

Review of the Role of the Brain in Chemotherapy-Induced Peripheral Neuropathy
por: Omran, Maryam, et al.
Publicado: (2021)

Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice
por: Bernard, Amandine, et al.
Publicado: (2022)

Vincristine-Induced Neuropathy in Patients Diagnosed with Solid and Hematological Malignancies: The Role of Dose Rounding
por: Alwhaibi, Abdulrahman M., et al.
Publicado: (2023)

Unusual Manifestations of Vincristine Neuropathy: Report of Two Cases of Hodgkin Lymphoma
por: Akay, Olga Meltem, et al.
Publicado: (2014)

Mechanisms Underlying Gastrodin Alleviating Vincristine-Induced Peripheral Neuropathic Pain
por: Wang, Xiangyu, et al.
Publicado: (2021)

Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial)
por: van de Velde, Mirjam Esther, et al.
Publicado: (2020)

Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat
por: Vera, Gema, et al.
Publicado: (2017)

Centrosomal protein72 rs924607 and vincristine-induced neuropathy in pediatric acute lymphocytic leukemia: meta-analysis
por: Zečkanović, Aida, et al.
Publicado: (2020)

Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients
por: Tay, Nicolette, et al.
Publicado: (2022)

Risk Factors for Early-Onset Peripheral Neuropathy Caused by Vincristine in Patients With a First Administration of R-CHOP or R-CHOP-Like Chemotherapy
por: Okada, Naoto, et al.
Publicado: (2014)

Anemia Is a Novel Predictive Factor for the Onset of Severe Chemotherapy-Induced Peripheral Neuropathy in Lymphoma Patients Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone Therapy
por: Saito, Takashi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mv0ebhsl0kk5sinhj5chkqj6j2